Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
PubChem
DailyMed
Druglib
Clinicaltrials.gov
Chemistry and Pharma Blogs:
The Science Business
Org Prep Daily
Kilomentor
On Pharma
Kinase Pro
Pharma Conduct
Chemical Quantum Images
The LouRoe
One in Ten Thousand
Periodic Tabloid
Chemical Musings
C&E News Blog
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Chirality

BBSRC/Douglas Kell
Drug Discovery Opinion
The Chemblog
Realizations in Biostatistics
Molecule of the Day
Chemjobber
Pharmalot
WSJ Health Blog
Chemical Crystallinity
ChemSpider Blog
Pharmagossip
Med-Chemist
Organometallic Current
Useful Chemistry
Chiral Jones
Great Molecular Crapshoot
No Name No Slogan
SimBioSys
Culture of Chemistry
The Curious Wavefunction
Chemical Sabbatical
Totally Synthetic
Zusammen
My Chemical Journey
The F- Blog
Generally Chemistry
Chemistry World Blog
Synthetic Nature
Synthesizing Ideas
Carbon-Based Curiosities
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
P212121
Curly Arrow
ChemCafe
Power of Goo
Fetz the Chemist
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa
Pharma Blog Review


Science Blogs and News:
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Life of a Lab Rat
Nobel Intent
SciTech Daily
Is This Thing On?
Science Blog
Eastern Blot
FuturePundit
Flags and Lollipops
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Terra Sigillata
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Living the Scientific Life
Humans in Science
Speculist
Science, Shrimp and Grits
Cosmic Variance
The Capsule
Zeroth Order Approximation
Science Library Blog
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Supplies of Suppliers | Main | Hexacyclinol: A Forensic Case »

February 18, 2009

Business Books: The Enantiomers

Email This Entry

Posted by Derek

Since I wrote about business books the other day, and not in a complimentary fashion, reader David Shaywitz sent along a note about his piece in Forbes on reading for newly-humbled CEOs.

Included are intriguing titles like The Halo Effect: ... and the Eight Other Business Delusions That Deceive Managers, which is billed as "a tart takedown of fashionable management theories" and vigorously named Hard Facts, Dangerous Half-Truths And Total Nonsense. Worth a look for people who need (or want) to read about management, but don't find themselves with much to work with from the big bestsellers.

Comments (7) + TrackBacks (0) | Category: Business and Markets


COMMENTS

1. RB Woodweird on February 19, 2009 7:34 AM writes...

Breaking management of their buzzword program addiction is like trying to get my mother in law to give up cigarettes. They will read the books and swear that they won't be fooled again, but they will light up sooner rather than later. They can't help it. If they were rational thinkers, they'd be scientists.

To carry the nicotine analogy along, there is a whole industry devoted to - and pretty effective at - keeping management brains craving that next big paradigm-shifting, productivity-enhancing, working-smarter-not-harder hit of sixsigma. These pushers get their whispers into the right ears: "Your competitors are doing this. Everyone will be doing this soon. You don't want to be behind the curve, do you? When the CEO calls you, you want to be able to say you already set up the trainings, don't you?" And if everyone is doing it or about to be doing it, then it is like going with IBM circa 1970. Nobody ever got fired for running up the 5S banner.

All you can do is sing the song, hang the posters, mouth the slogans - all while ignoring them. You have to pretend they are your wife and just yes dear to anything. Never contradict, and for God's sake never suggest they read books like are mentioned in the blog above.

Permalink to Comment

2. Alaster on February 19, 2009 9:43 AM writes...

If you liked The Halo Effect, then another you may like is Fooled by Randomness by Nicholas Taleb

Permalink to Comment

3. Tok on February 19, 2009 10:17 AM writes...

Humbled CEOs eh? I'll bet they're humbled all the way to the bank. What personal consequences are there for a CEO who drives a company into the ground? None.

Permalink to Comment

4. Hap on February 19, 2009 1:36 PM writes...

I don't want CEOs who fail to have to wear a scarlet A or anything, but not profiting extravagantly from their failures would be an improvement. If you profit significantly from the success of your company, than you should suffer consequences when the company doesn't succeed - otherwise the "risk argument" for why CEOs (and other executives) make so much more money than other employees holds no water. I don't know if it's fair to expect of anyone at their job level, but it would be nice if CEOs actually had to suffer similar consequences to those of the people who were laid off for the CEO's failures. They have to take risks, and sometimes risks don't pan out, but maybe hanging out at the unemployment office for a few weeks would make them somewhat less willing to take stupid risks (or, on the other hand, maybe they would take larger risks, to cash out as much as is possible when they get the chance).

The only solution is substantial investor oversight - if stockholders have little or no say in the decisions of the company, then the board and the executives can act for their own benefits rather than those of their employers (and you get what you have now).

Permalink to Comment

5. make money from blogging on February 20, 2009 2:54 AM writes...

This is going to be a lot of fun . There are so many theories floating around.

Permalink to Comment

6. SRC on February 21, 2009 3:37 PM writes...

Excellent post, RB Woodweird. The problem is that to resist running blindly with the herd, one has to be pretty strong-minded and confident in one's own intellect and judgment.

Management types generally seem not to be overly endowed with any of those qualities. Thus the suggestion that there are people smarter than they (God knows that's a big club) who know something they don't (again, a very low bar) and are stealing a march on them strikes them with mortal terror that they'll be exposed at imposters or at least not up to speed with the current thinking. (Think teenagers who haven't yet adopted the latest fashion.)

Result: they plunge into yet another management fad, trying to make up in fervor what they lacked in timing, wasting lots of time and money. Then the next fad comes along...

Permalink to Comment

7. CMC Guy on February 22, 2009 4:10 PM writes...

SRC although I deplore and criticize what MBA mentality has done to business, and Pharma in particular, I disagree that the qualities mentioned are generally lacking in most of Management. If fact I would argue many of those characteristics are currently over valued in most cases and has been responsible for "success", it is just not focused on doing things differently and leads to arrogance.

IMO this is just aspects of Human Nature and I think Scientists can also suffer from the same type attitudes (to greater degree in some instances) with similar resulting advantages/disadvantages. How many times have this blog discussed various "drug discovery fads" that have occurred over past 20 years so we here are not immune.

We can be frustrated by (and laugh at) all the management "buzz-words" and contradictions but does not it comes down to attempts to make complex things simple and if there was a single working formula why has it not been found and implemented. It is another Human tendency to stick with the herd and even though as Scientists part of our training is to explore new areas it is rare when someone can break away from existing norms or paths. In the end in Pharma we need input from many disciplines, including business types, and we all need to work and build together to truly be successful.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Dealing With Hedgehog Screening Results
Animal Rights, You Say?
Blogroll Update
Pharma's Return on Investment: Yikes
How A Real Drug Industry Project Meeting Goes
Ghostwriting
Just Give It to NIH
How Not To Do It: The Secret Patent Decoder Ring